The presence of extracellular amyloid-beta (A beta) plaques is one of the pathological hallmarks of Alzheimer's disease. Appropriately functionalized compounds can modulate amyloidogenesis. Here, we report a new class of cyclodextrin (CyD) derivatives rationally designed to improve the A beta recognition and to modulate its aggregation. In particular, a dimethylamino aromatic moiety was conjugated to beta CyD or gamma CyD to explore how different structural aspects of these derivatives could influence the recognition and the aggregation of A beta. The conjugation of the A beta recognition moiety to CyDs resulted in a significant suppression of the self-assembly propensity of A beta when the dimethylamino aromatic moiety was attached to the upper rim of beta CyD. The activity of the derivatives toward A beta confirms that the conjugation of CyDs with A beta recognition moieties may be considered a promising approach for designing new molecules that interfere with A beta aggregation.

Synthesis and Evaluation of New Cyclodextrin Derivatives as Amyloid-β Aggregation Inhibitors

Oliveri V.
;
Vecchio G.
2019

Abstract

The presence of extracellular amyloid-beta (A beta) plaques is one of the pathological hallmarks of Alzheimer's disease. Appropriately functionalized compounds can modulate amyloidogenesis. Here, we report a new class of cyclodextrin (CyD) derivatives rationally designed to improve the A beta recognition and to modulate its aggregation. In particular, a dimethylamino aromatic moiety was conjugated to beta CyD or gamma CyD to explore how different structural aspects of these derivatives could influence the recognition and the aggregation of A beta. The conjugation of the A beta recognition moiety to CyDs resulted in a significant suppression of the self-assembly propensity of A beta when the dimethylamino aromatic moiety was attached to the upper rim of beta CyD. The activity of the derivatives toward A beta confirms that the conjugation of CyDs with A beta recognition moieties may be considered a promising approach for designing new molecules that interfere with A beta aggregation.
Alzheimer; amyloid aggregation; cyclodextrins; dimethylamino functionality; fibrils; neurodegeneration
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/20.500.11769/372163
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 3
social impact